Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May;29(4):178-84.
doi: 10.1155/2015/824263.

Hepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting

Kelly Warren Burak, Morris Sherman

Hepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting

Kelly Warren Burak et al. Can J Gastroenterol Hepatol. 2015 May.

Abstract
in English, French

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide and its incidence has rapidly increased in North America in recent years. Although there are many published guidelines to assist the clinician, there remain gaps in knowledge and areas of controversy surrounding the diagnosis and management of HCC. In February 2014, the Canadian Association for the Study of the Liver organized a one-day single-topic consensus conference on HCC. Herein, the authors present a summary of the topics covered and the result of voting on consensus statements presented at this meeting.

Le carcinome hépatocellulaire (CHC) est une cause majeure de mortalité liée au cancer dans le monde. Ces dernières années, son incidence a augmenté rapidement en Amérique du Nord. Même si de nombreuses directives sont publiées pour venir en aide au clinicien, il reste des lacunes et des controverses à l’égard du diagnostic et de la prise en charge du CHC. En février 2014, l’Association canadienne pour l’étude du foie a organisé une conférence consensuelle d’une journée entièrement consacrée au CHC. Dans le présent article, les auteurs présentent un résumé des sujets traités et les résultats des votes sur les déclarations consensuelles qui y ont été présentées.

PubMed Disclaimer

Figures

Figure 1)
Figure 1)
Demographics of voters. GI Gastroenterology; HCC Hepatocellular carcinoma; yrs Years
Figure 2)
Figure 2)
Algorithm for the diagnosis of hepatocellular carcinoma (HCC) after identification of a lesion on a surveillance ultrasound. CT Computed tomography; MRI Magnetic resonance imaging. Adapted with permission from reference
Figure 3)
Figure 3)
Barcelona Clinic Liver Cancer stages and allocation of treatment. CP Child-Pugh class; LT Liver transplantation; PS Eastern Cooperative Oncology Group performance status; TACE Transarterial chemoembolization. Adapted with permission from reference
See this image and copyright information in PMC

References

    1. Sherman M, Burak K, Maroun J, et al. Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma. Curr Oncol. 2011;18:228–40. - PMC - PubMed
    1. Bruix J, Sherman M, American Association for the Study of Liver Diseases Management of hepatocellular carcinoma: An update. Hepatology. 2011;53:1020–2. - PMC - PubMed
    1. European Association For The Study Of The Liver; European Organization For Research And Treatment Of Cancer EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol. 2012;56:908–43. - PubMed
    1. Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4:439–74. - PMC - PubMed
    1. Public Health Agency of Canada Mortality Statistics. < www.phacaspc.gc.ca/sti-its-surv-epi/model/pdf/model07-eng.pdf> (Accessed February 1, 2014).

Publication types

MeSH terms